Clinical Trials Logo

Clinical Trial Summary

There is a complex, mutual relationship between cancer and thrombosis. Indeed, the tumor has the capacity to activate the hemostatic system and this leads to an increased thrombotic risk in cancer patients. Even in the absence of clinical manifestations, cancer patients are commonly characterized by hemostatic abnormalities, recognized only by laboratory testing, which define the 'hypercoagulable state'. Of interest, hypercoagulation has been repeatedly reported to be associated with tumor progression and poor prognosis in various carcinomas. On the other hand, thrombotic event can represent the first signal of the presence of an occult tumor. These findings suggest that the coagulant pathway might play a role in the preclinical phase of cancer. The investigators hypothesize that a persistent, subclinical activation of the hemostatic system in an otherwise healthy subject, may predispose not only to thrombosis, but also to tumor formation and spreading. A major problem in primary cancer prevention is the lack of effective predictive markers of the disease. The HYPERCAN is an ongoing prospective Italian multicenter study organized around two tightly-interconnected research programs aiming to: 1_the assessment of thrombotic markers as a tool for cancer risk prediction in two large populations of healthy subjects, i.e. a group of healthy blood donors of Bergamo and Milano Provinces and a subgroup of Moli-sani subjects of the Molise region; and 2_ the evaluation whether thrombotic markers and/or the occurrence of overt thrombosis (or disseminated intravascular coagulation) may be prognostic of cancer disease outcomes (i.e. overall survival, progression free survival in metastatic cancer, disease free survival in limited disease) in cancer patients with different types of solid tumors (i.e. breast, lung and gastrointestinal cancers).

Therefore, the assessment of cancer risk occurrence in healthy individuals might be useful for anticipation of cancer diagnosis. In addition, the results of this study might help to evaluate whether thrombotic markers may be prognostic of cancer outcomes independently of the disease extension.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02622815
Study type Observational
Source A.O. Ospedale Papa Giovanni XXIII
Contact Anna Falanga, MD
Phone +39-035.267.8597
Email annafalanga@icthic.com
Status Recruiting
Phase
Start date April 2012
Completion date January 2020

See also
  Status Clinical Trial Phase
Completed NCT03707548 - BPT to Improve Bodily Disturbances in Post-treatment Cancer Patients N/A
Not yet recruiting NCT06463782 - Clinical Study of 68Ga-LNC1007 Injection PET/CT Phase 1
Not yet recruiting NCT04493450 - NEMO - an App for Side Effect Management in Oncology
Completed NCT05604820 - The Effect of Progressive Muscle Relaxation Exercise on Sleep Quality N/A
Completed NCT04024748 - Verification of Imaging System PCD-1000A
Completed NCT03320161 - A Patient Consensus for the Research in Supportive Care in French Cancer Care Centers: the CyPRES Project
Recruiting NCT05547282 - Low-dose Radiotherapy Combined With Conventional Radiotherapy After Immunotherapy Failure N/A
Recruiting NCT01742143 - Impact of ICCAN on Cancer Treatment Completion and Quality of Life
Completed NCT05368116 - Effectiveness of Video Assisted Self Management Program on Chemotherapy Related Side Effects . N/A
Recruiting NCT01603316 - Food: A Three-Arm Study Examining Food Insecurity Interventions Phase 2
Recruiting NCT03100071 - Central Venous Catheter (CVC) Associated Deep Vein Thrombosis (DVT) in Cancer Patients
Completed NCT04037410 - Environmental Temperature and White Adipose Tissue in Cancer Patients
Recruiting NCT06305741 - A Study of an Anxiety Intervention for Latino/Latina/Hispanic Older Adults With Cancer and Their Caregivers N/A
Recruiting NCT05279378 - Correlation of Lung Ultrasonography With Chest CT Findings in Cancer Patients With COVID-19 Viral Pneumonia
Completed NCT03536702 - Effect of Group Led Creative Writing on Mood in Cancer Patients N/A
Not yet recruiting NCT05922423 - Exploration of Management Model and Intervention Research on Fear of Cancer Recurrence N/A
Completed NCT01704469 - A Comparison of the Perception of a Needle Injection Pain Between Cancer Patients Receiving Opioid Therapy Versus Opioid-naive Patients N/A
Active, not recruiting NCT06348940 - Effects of Behavioral Activation on Negative Emotions, Cancer-related Symptoms and Clinical Indicators in Cancer Patients N/A
Completed NCT04302792 - New Food Solutions for Cancer Patients N/A
Recruiting NCT05219851 - The Risk Factors for Acute Radiation Pneumonitis in Patients With Prior Receipt of Immune Checkpoint Inhibitors